Yes, KGF can be beneficial in cancer therapy. For instance, recombinant human KGF (palifermin) is used to reduce the severity and duration of oral mucositis in patients undergoing high-dose chemotherapy and radiation therapy for hematologic cancers. By promoting the regeneration of epithelial cells, KGF helps in reducing treatment-related complications.
